Volume Spike Investor

These are five big movers in after-hours trading right before 6:00 PM EST: Sprint Nextel (NYSE: S) is up over 6% at $4.42 after closing up more than 3% today, and Clearwire (NASDAQ: CLWR) is up 15% after-hours at $11.25 after closing up 5% at $9.85.  The companies have received FCC approval for the wireless [...]

Animal Health International Inc. (NASDAQ: AHII) looks to be today’s worst performing stock.  The company missed earnings by a wide margin.  Earnings were $0.01 EPS vs, Thomson Reuters (First Call) estimates of $0.11 EPS.  Revenues rose almost 3% to $169 million, but that is also under the $178.9 million estimate. The company now sees Fiscal-2009 [...]

CIT Group Inc. (NYSE: CIT) is seeing its shares surge as one the top percentage gainers today after the company announced that it has completed a $500 million financing facility. The credit facility is via Wells Fargo & Co. and it will give CIT access for up to $500 million in secured financing.  This is [...]

Archer-Daniels-Midland Co. (NYSE: ADM) is surging right before the open.  The company blew past earnings estimates and it is being rewarded after losing so much ground this year. Shares are up 13% at $24.00 on over 115,000 shares at 9:26 AM EST.  The average volume is 9 million shares and the 52-week trading range is [...]

Marvell Technology Group Ltd. (NASDAQ: MRVL) is surging this morning.  What is interesting is that this particular price surge is on an earnings warning. On the surface it also looks like a fairly ugly warning even for the current environment (details here).  It seems that maybe the bullish sentiment in th market and some efficiency [...]

Myriad Genetics Inc. (NASDAQ: MYGN) announced this morning that the company beat earnings significantly with $0.30 EPS and $73.7 million in revenues.  Thomson Reuters (First Call) estimates were $0.14 EPS and $70.4 million in revenues. The biotech company also said it remains in strong financial condition with $443 million in cash and equivalents.  Its market [...]

Osiris Therapeutics (NASDAQ: OSIR) is seeing its stock surge pre-market after signing a pact with Genzyme (NASDAQ: GENZ) to develop and commercialize adult stem cell products.  Genzyme will pay out cash and will make an up-front payment of $130 million to Osiris, which is substantial to the $493 million market cap as of yesterday.  Osiris [...]